Wszolek ZK - Search Results

1

Cerebrospinal fluid amyloid β and tau in LRRK2 mutation carriers.

Aasly JO, Shi M, Sossi V, Stewart T, Johansen KK, Wszolek ZK, Uitti RJ, Hasegawa K, Yokoyama T, Zabetian CP, Kim HM, Leverenz JB, Ginghina C, Armaly J, Edwards KL, Snapinn KW, Stoessl AJ, Zhang J. Aasly JO, et al. Among authors: wszolek zk. Neurology. 2012 Jan 3;78(1):55-61. doi: 10.1212/WNL.0b013e31823ed101. Epub 2011 Dec 14. Neurology. 2012. PMID: 22170881 Free PMC article.

2

Western Nebraska family (family D) with autosomal dominant parkinsonism.

Wszolek ZK, Pfeiffer B, Fulgham JR, Parisi JE, Thompson BM, Uitti RJ, Calne DB, Pfeiffer RF. Wszolek ZK, et al. Neurology. 1995 Mar;45(3 Pt 1):502-5. doi: 10.1212/wnl.45.3.502. Neurology. 1995. PMID: 7898705

3

Genetic linkage studies in autosomal dominant parkinsonism: evaluation of seven candidate genes.

Gasser T, Wszolek ZK, Trofatter J, Ozelius L, Uitti RJ, Lee CS, Gusella J, Pfeiffer RF, Calne DB, Breakefield XO. Gasser T, et al. Among authors: wszolek zk. Ann Neurol. 1994 Sep;36(3):387-96. doi: 10.1002/ana.410360310. Ann Neurol. 1994. PMID: 7915897

4

Genetic linkage studies in autosomal dominantly inherited L-DOPA responsive parkinsonism. Evaluation of candidate genes.

Gasser T, Wszolek Z, Supala A, Trofatter J, Ozelius L, Uitti RJ, Pfeiffer RF, Gusella J, Calne D, Breakefield XO. Gasser T, et al. Adv Neurol. 1996;69:87-95. Adv Neurol. 1996. PMID: 8615189 Clinical Trial. No abstract available.

5

Olfactory dysfunction in familial parkinsonism.

Markopoulou K, Larsen KW, Wszolek EK, Denson MA, Lang AE, Pfeiffer RF, Wszolek ZK. Markopoulou K, et al. Among authors: wszolek zk, wszolek ek. Neurology. 1997 Nov;49(5):1262-7. doi: 10.1212/wnl.49.5.1262. Neurology. 1997. PMID: 9371905

6

PET studies of parkinsonism associated with mutation in the alpha-synuclein gene.

Samii A, Markopoulou K, Wszolek ZK, Sossi V, Dobko T, Mak E, Calne DB, Stoessl AJ. Samii A, et al. Among authors: wszolek zk. Neurology. 1999 Dec 10;53(9):2097-102. doi: 10.1212/wnl.53.9.2097. Neurology. 1999. PMID: 10599788

7

A mutation in the microtubule-associated protein tau in pallido-nigro-luysian degeneration.

Wszolek ZK, Uitti RJ, Hutton M. Wszolek ZK, et al. Neurology. 2000 May 23;54(10):2028-30. doi: 10.1212/wnl.54.10.2028. Neurology. 2000. PMID: 10822460 No abstract available.

8

Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene.

Wszolek ZK, Tsuboi Y, Uitti RJ, Reed L. Wszolek ZK, et al. Neurology. 2000 Dec 26;55(12):1939. doi: 10.1212/wnl.55.12.1939. Neurology. 2000. PMID: 11134413 No abstract available.

9

Positron emission tomography in pallido-ponto-nigral degeneration (PPND) family (frontotemporal dementia with parkinsonism linked to chromosome 17 and point mutation in tau gene).

Pal PK, Wszolek ZK, Kishore A, de la Fuente-Fernandez R, Sossi V, Uitti RJ, Dobko T, Stoessl AJ. Pal PK, et al. Among authors: wszolek zk. Parkinsonism Relat Disord. 2001 Apr;7(2):81-88. doi: 10.1016/s1353-8020(00)00026-2. Parkinsonism Relat Disord. 2001. PMID: 11248587

10

Progressive supranuclear palsy as a disease phenotype caused by the S305S tau gene mutation.

Wszolek ZK, Tsuboi Y, Uitti RJ, Reed L, Hutton ML, Dickson DW. Wszolek ZK, et al. Brain. 2001 Aug;124(Pt 8):1666-70. doi: 10.1093/brain/124.8.1666. Brain. 2001. PMID: 11459757 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

714 results

Search Page